A Phase 3 Study of LNK01001 Capsule in Subjects With Moderate to Severe Atopic Dermatitis.

Clinical trial NCT06277245 · COMPLETED

Trial details

NCT number: NCT06277245
Sponsor: Lynk Pharmaceuticals Co., Ltd
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Atopic Dermatitis

Start date: 2024-02-06
Primary completion: 2025-04-18
Enrollment: 356

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.